Ghana: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Ghana

The Ghanian prophylactic medicaments containing insulin market shrank dramatically to $X in 2022, with a decrease of -15.3% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption showed a abrupt setback. Prophylactic medicaments containing insulin consumption peaked at $X in 2013; however, from 2014 to 2022, consumption stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Ghana

Prophylactic medicaments containing insulin exports from Ghana reduced sharply to X kg in 2019, declining by -33.3% compared with the year before. Overall, exports continue to indicate a relatively flat trend pattern. Over the period under review, the exports reached the maximum at X kg in 2018, and then shrank markedly in the following year.

In value terms, prophylactic medicaments containing insulin exports declined markedly to $X in 2019. Over the period under review, exports, however, continue to indicate a temperate expansion. Over the period under review, the exports hit record highs at $X in 2018, and then reduced sharply in the following year.

Exports by Country

Costa Rica (X kg) was the main destination for prophylactic medicaments containing insulin exports from Ghana, accounting for a 50% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Costa Rica exceeded the volume sent to the second major destination, South Africa (X kg), threefold. The United States (X kg) ranked third in terms of total exports with a 17% share.

From 2013 to 2019, the average annual growth rate of volume to Costa Rica was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: South Africa (0.0% per year) and the United States (0.0% per year).

In value terms, Costa Rica ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Ghana, comprising 99% of total exports. The second position in the ranking was held by South Africa ($X), with a 0.2% share of total exports. It was followed by the United States, with a 0.2% share.

From 2013 to 2019, the average annual rate of growth in terms of value to Costa Rica was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: South Africa (0.0% per year) and the United States (0.0% per year).

Export Prices by Country

In 2019, the average prophylactic medicaments containing insulin export price amounted to $X per ton, growing by 23% against the previous year. Overall, the export price recorded noticeable growth. As a result, the export price reached the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices for the major overseas markets. In 2019, amid the top suppliers, the country with the highest price was Costa Rica ($X per ton), while the average price for exports to the UK ($X per ton) was amongst the lowest.

From 2013 to 2019, the most notable rate of growth in terms of prices was recorded for supplies to the UK (-75.0%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Ghana

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Ghana reduced remarkably to X tons, with a decrease of -17.1% on the previous year. Over the period under review, imports showed a perceptible slump. The most prominent rate of growth was recorded in 2015 when imports increased by 406% against the previous year. Over the period under review, imports hit record highs at X tons in 2013; however, from 2014 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports dropped to $X in 2022. Overall, imports continue to indicate a abrupt descent. The pace of growth was the most pronounced in 2015 with an increase of 334%. Over the period under review, imports hit record highs at $X in 2013; however, from 2014 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, Egypt (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Ghana, with a 80% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Egypt exceeded the figures recorded by the second-largest supplier, Denmark (X tons), eightfold. The third position in this ranking was taken by Switzerland (X kg), with a 2.8% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Egypt amounted to +7.1%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (-12.9% per year) and Switzerland (-6.9% per year).

In value terms, Egypt ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Ghana, comprising 87% of total imports. The second position in the ranking was taken by Denmark ($X), with a 4.8% share of total imports. It was followed by Switzerland, with a 3.1% share.

From 2012 to 2022, the average annual growth rate of value from Egypt stood at -2.0%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (-30.0% per year) and Switzerland (-14.2% per year).

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, growing by 5.8% against the previous year. Overall, the import price, however, continues to indicate a abrupt descent. The most prominent rate of growth was recorded in 2019 when the average import price increased by 42% against the previous year. Over the period under review, average import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Switzerland ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (-4.1%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :